Physician profile
Maria E Levada
NPI 1558406215
$2,127.61
in general payments reported to CMS, 2019-2025
22 companies · $310 in 2025
The $310 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $345 · 2020: $64.87 · 2021: $367 · 2022: $436 · 2023: $271 · 2024: $334 · 2025: $310.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $725 · Education: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.90 |
| Education | $189.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $378.64 | 2020-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $374.55 | 2019-2025 | |
| Exeltis, USA INC. | $225.59 | 2019-2025 | Slynd |
| Lupin INC. | $168.49 | 2019-2020 | |
| Allergan, INC. | $160.71 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $112.86 | 2023-2025 | Myfembree, Gemtesa |
| Revance Therapeutics, INC. | $106.31 | 2024 | Daxxify |
| Myovant Sciences INC. | $89.71 | 2021-2022 | |
| Scynexis, INC. | $87.89 | 2021-2022 | |
| Therapeuticsmd, INC. | $67.99 | 2019-2021 | |
| Exact Sciences Corporation | $64.11 | 2023-2024 | Cologuard Collection Kit |
| Amag Pharmaceuticals, INC. | $45.54 | 2019 | |
| Mayne Pharma Commercial LLC | $43.16 | 2021-2025 | |
| Millicent US INC | $38.34 | 2019-2021 | |
| Smith+Nephew, INC. | $26.67 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtus Pharmaceuticals LLC | $23.44 | 2022 | |
| Azurity Pharmaceuticals, INC. | $22.47 | 2023 | Adthyza |
| Acella Pharmaceuticals, LLC | $21.45 | 2025 | NP Thyroid 60 |
| Agile Therapeutics, INC. | $20.31 | 2021 | |
| Coopersurgical, INC. | $19.07 | 2022 | |
| Pfizer INC. | $15.20 | 2023 | |
| Avion Pharmaceuticals | $15.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Levada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.